 WARREN, N.J., Nov. 09, 2022 GLOBE NEWSWIRE -- Aquestive Therapeutics, Inc. NASDAQ: AQST, a pharmaceutical company advancing current standards of care to solve patients problems through simplifying complex delivery methods, will present three abstracts recapping positive data from its completed pharmacokinetic studies of AQST-109 epinephrine sublingual film at the American College of Allergy Asthma and Immunology ACAAI Annual Scientific Meeting, which will be held from November 10-14, in Louisville, Kentucky. 